AI Analysis of 3D Eye Scans Can Detect Signs of Parkinson's Disease

2023-08-24

A new study has found that 3D eye scanning technology used in eye clinics and high street opticians can detect signs of Parkinson's disease up to seven years before clinical symptoms appear.

Using eye data to identify health conditions is not new in the field of medicine. However, advancements in eye health monitoring technology and computational power in recent years have expanded the scope of diagnosis.

A 3D scanning technology called Optical Coherence Tomography (OCT) has played a key role in this progress. OCT scans can generate cross-sectional images of the retina (the back of the eye) with astonishing detail in less than a minute, with an accuracy of up to one-thousandth of a millimeter. Retinal scans provide the only non-invasive way to observe the cellular layers beneath the skin surface.

As part of this study, a research team from University College London (UCL) and Moorfields Eye Hospital analyzed OCT scan results from two large databases: AlzEye and the UK Biobank, which included 154,830 and 67,311 individuals, respectively.

The study confirmed the previously observed thinning of the ganglion cell-inner plexiform layer (GCIPL) in Parkinson's disease patients. The data also revealed atrophy of the inner nuclear layer (INL). Furthermore, the researchers found that the thinning of these two layers is associated with disease progression.

While further research is still needed, Dr. Siegfried Wagner, the lead author of the study, hopes that this method will soon become a pre-screening tool for individuals at risk of developing Parkinson's disease.

He said, "Detecting signs of various diseases before symptoms appear means that people have time to make lifestyle changes to prevent certain conditions from occurring, and clinicians can also delay the onset and impact of neurodegenerative diseases that alter lives."

Meanwhile, a team led by Professor Pearse Keane, a senior author of the study, has secured funding from UK Research and Innovation to expand and validate the underlying model.

This study adds value to the field of "ophthomics," which utilizes machine learning and eye scanning data to reveal signs of diseases such as Alzheimer's and multiple sclerosis.

RECENT AI NEWS

RECENT AI TOOLS